¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"acute yellow atrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • acute hemolytic anemia
    ±Þ¼º ¿ëÇ÷¼º ºóÇ÷(?ËíÌ´ËÛË×Ì´).
  • acute hemolytic transfusion reaction
    ±Þ¼º¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
  • acute hemorrhagic conjunctivitis
    ±Þ¼ºÃâÇ÷¼º°á¸·¿°
  • acute hemorrhagic conjunctivitis
    ±Þ¼ºÃâÇ÷°á¸·¿°
  • acute hemorrhagic cystitis
    ±Þ¼º ÃâÇ÷¼º ¹æ±¤¿°
  • acute hemorrhagic pancreatitis
    ±Þ¼º ÃâÇ÷¼º ÃéÀå¿°(¡­õóúìàõõýíôæú).
  • acute hepatic insufficiency
    ±Þ¼º °£ºÎÀü.
  • acute hepatitis
    ±Þ¼º °£¿°
  • acute herpetic gingivostomatitis
    ±Þ¼ºÆ÷Áø¼º Ä¡Àº±¸³»¿°, ±Þ¼ºÇ츣Æä½º Ä¡Àº±¸³»¿°
  • acute hydramnion
    ±Þ¼º ¾ç¼ö°ú´Ù(Áõ)(¡­åÏâ©Î¦Òýñø).
  • acute hydrocephaly
    ±Þ¼º ¼öµÎÁõ(¡­â©Ôéñø).
  • acute hydrops
    ±Þ¼º¼öÁõ
  • acute hypoxia
    ±Þ¼ºÀú»ê¼Ò»óÅ , -Áõ
  • acute hypoxic encephalopathy
    ±Þ¼º Àú»ê¼Ò¼º ³úº´Áõ(¡­î¸ß«áÈàõÒàÜ»ñø).
  • acute idiopathic polyneuritis
    ±Þ¼º Ư¹ß¼º ´Ù¹ß½Å°æ¿°(¡­÷åÛ¡àõÒýÛ¡ãêÌèæú).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • muscular atrophy
    ±Ù À§Ãà(ÐÉê×õê).
  • muscular atrophy
    ±ÙÀ§Ãà(¡­ê×õê)
  • muscular atrophy
    ±ÙÀ§Ãà(ÐÉê×õê).
  • myelopathic muscular atrophy
    ô¼öº´Áõ¼º ±ÙÀ§Ãà.
  • myopathic atrophy
    ±Ùº´¼º À§Ãà(ÐÉÜ»àõê×õê), ±Ùº´Áõ¼º À§Ãà.
  • myopathic atrophy
    ±Ùº´Áõ¼º À§Ãà.
  • myopathic progressive muscular atrophy
    ±Ùº´Áõ¼º ÁøÇ༺ ±ÙÀ§Ãà(Áõ)(¡­òäú¼àõÐÉê×õêñø).
  • neural progressive muscular atrophy
    ½Å°æ¼º ÁøÇ༺ ±ÙÀ§Ãà(Áõ).
  • neural progressive muscular atrophy
    ½Å°æ¼º ÁøÇ༺ ±ÙÀ§Ãà(Áõ)(¡­òäú¼àõ ÐÉê×õêñø)
  • neurogenic muscular atrophy
    ½Å°æ¼º ±ÙÀ§Ãà(Áõ).
  • neurospinal muscular atrophy
    ½Å°æÃ´¼ö¼º±ÙÀ§Ãà(~ô±âÐàõÐÉê×õê).
  • nutritional optic atrophy
    ¿µ¾ç½Ã½Å°æÀ§Ãà
  • olivopontocerebellar atrophy
    ¿Ã¸®ºê±³(¿Ã¸®ºê³ú±³)¼Ò³úÀ§Ãà(¡­ÒàÎéá³Òàê×õê)
  • olivopontocerebellar atrophy =OPCA
    ¿Ã¸®ºê±³¼Ò³úÀ§Ãà(¡­Îéá³Òàê×õê).
  • olivopontocerebellar atrophy =opca
    ¿Ã¸®ºê±³¼Ò³úÀ§Ãà(¡­Îéá³Òàê×õê)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
atr atrophy
CA anterior commissure [Lat. commissura anterior]; calcium antagonist; California [rabbit]; cancer; Can...
CSMA chronic spinal muscular atrophy
DIDMOA diabetes insipidus-diabetes mellitus-optic atrophy [syndrome]
DIDMOAD diabetis insipidus, diabetes mellitus, otpic atrophy, deafness [syndrome]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
EYFP enhanced yellow fluorescent protein
OYL of the yellow ligament
SYF small yellow follicles
Y yellow
APRF 3/acute phase response factor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute inflammatory demyelinating polyradiculoneuropathy
    ±Þ¼º ¿°Áõ¼º ´Ù¹ß½Å°æ¿°
    ¾ÆÁ÷µµ È®½ÇÇÏÁö ¾ÊÁö¸¸ ¸é¿ª¹ÝÀÀÀ» ÅëÇÏ¿© ³ªÅ¸³­´Ù°í ¾Ë·ÁÁ® ÀÖ´Â ½Å°æº´ÁõÀÌ´Ù. ÀÓ»óÀûÀ¸·Î´Â ±Þ¼ÓÈ÷ ÁøÇàÇÏ´Â ¿îµ¿½Å°æº´ÁõÀ¸·Î ÇÏÁö¿¡¼­ ½ÃÀÛÇÏ¿© »óÁö·Î ÁøÇàµÇ¸ç, Á¤µµÀÇ Â÷À̸¦ °¡Áø °¨°¢Àå¾Ö¸¦ µ¿¹ÝÇÑ´Ù.
  • acute intermittent porphyria
    ±Þ¼º °£Ç漺 Æ÷ÇÁÇǸ°Áõ
    Æ÷¸£ÇǸ°Áõ °¡¿îµ¥ °¡Àå ¸¹Àº °ÍÀÌ°í ¾à°£ ¿©¼º¿¡°Ô ¸¹Àºµ¥ »ó¿°»öü ¿ì¼º À¯ÀüÀ» ÇÑ´Ù´Â °ÍÀÌ ¾Ë·ÁÁ® ÀÖ´Ù. º¹Åë, ±¸Åä, º¯ºñ µîÀÇ º¹ºÎ Áõ»óÀÌ ±Þ¼º °£Ç漺À¸·Î »ý±â°í ¶§·Î´Â ¼±Åë°ú ºñ½ÁÇÒ ¶§°¡ ÀÖ´Ù. º¹ºÎ Áõ»ó¿¡ À̾î À̸¥¹Ù ´Ù¹ß¼º ½Å°æ¿°°ú °°Àº ½Å°æ Áõ»óÀÌ ³ªÅ¸³ª´Âµ¥, Á¤½Å Áõ»óµµ »ý±â´Â ¼ö°¡ ÀÖ´Ù. ¿ì·ÎÆ÷¸£ÇǸ®³ëÁ¨ 1ÀÇ ÇÕ¼º È¿¼ÒÀÇ À¯ÀüÀû ÀúÇϰ¡ ÀÖ°í Æä³ë¹ÙºñÅ» º¹¿ë µîÀÇ À¯Àο¡ ÀÇÇØ Çð ÇÕ¼ºÀÌ ´õ¿í ³·¾ÆÁö¸é Çǵå¹éÀûÀ¸·Î ¾Æ¹Ì³ë·¹ºê¸°»êÀ̳ª Æ÷¸£Æ÷ºô¸®³ëÁ¨ÀÇ Áõ»óÀÌ »ý±â°í ±× ¶§¹®¿¡ Áõ»óÀÌ ¹ß»ýÇÏ´Â °ÍÀ¸·Î µÇ¾î ÀÖ´Ù.
  • acute interstitial pneumonitis
    ±Þ¼º °£Áú¼º Æó·Å
  • acute isolated myocarditis
    ±Þ¼º ºÐ¸®¼º ½É±Ù¿°
  • acute lacunar tonsillitis
    ±Þ¼º ¼±¿Í Æíµµ¿°
  • acute laryngotracheal trauma
    ±Þ¼º Èĵαâ°ü ¿Ü»ó
  • acute leukemia
    ±Þ¼º ¹éÇ÷º´
    ¿ø¹ßÇÏ´Â Á¶Ç÷ Á¶Á÷À̳ª ¹éÇ÷º´ ¼¼Æ÷ÀÇ Á¾·ù¿¡ µû¶ó °ñ¼ö¼º, ¸²ÇÁ¼º, ´Ü±¸¼ºÀ¸·Î ³ª´µ¾îÁö°í Ư¼öÇÑ °ÍÀ¸·Î¼­ Àû¹éÇ÷º´, ÇüÁú ¼¼Æ÷¼º ¹éÇ÷º´, È£»ê±¸¼º ¶Ç´Â È£¿°±â¼º ¹éÇ÷º´ µîÀÌ ÀÖ´Ù.
  • acute leukosis
    ±Þ¼º ¹éÇ÷Áõ
  • acute locking
    ±Þ¼º °úµÎ°É¸²
  • acute lymphangitis
    ±Þ¼º ¸²ÇÁ°ü¿°
    ¸²ÇÁ°ü³»¿¡ ¼¼±Õ °¨¿°ÀÇ ÆÄ±Þ¿¡ ÀÇÇÏ¿© ¹ß»ýÇϸç, ¸²ÇÁ°üÀÇ °æ·Î¿¡ µû¶ó ÇÇÇÏ¿¡ ºÓÀº µ¿Å뼺 ÁÙ¹«´Ì°¡ ³ªÅ¸³­´Ù.
  • acute lymphoblastic leukemia
    ±Þ¼º ¸²ÇÁ¼º ¹éÇ÷º´
    1. À¯¾Æ ¹× ÀþÀº ¼ºÀο¡ È£¹ßÇÏ´Â Áúȯ. À¯¾Æ ±Þ¼º ¹éÇ÷º´ÀÇ »ó´ç¼ö¸¦ Â÷ÁöÇÑ´Ù. À¯¾Æ¿¡¼­ÀÇ È£¹ß ¿¬·ÉÀº 4¼¼ ÀüÈÄ. ÃÖ±Ù È­Çпä¹ýÀ¸·Î º´¿¡ °É¸° À¯¾ÆÀÇ 90%°¡ ¿ÏÀü Ä¡À¯µÈ´Ù. ¿¹ÈÄ´Â ¿¬·É, ¸é¿ªÇ¥ÇöÇü ±×¸®°í ¼¼Æ÷ À¯ÀüÇÐÀûÀÎ º¯È­¿¡ ÀÇÇØ ¿µÇâÀ» ¹Þ´Â´Ù. 2. ȯÀÚÀÇ 90%°¡ ¹éÇ÷±¸ ¼¼Æ÷¿¡¼­ ÇÙÇü ÀÌ»óÀ» º¸ÀδÙ. ÀϺΠ¼¼Æ÷À¯Àü º¯È­°¡ ¼ºº°, ¿¬·É, ¸é¿ªÇ¥ÇöÇü °°Àº º¯ÀÌ¿ä¼Ò¿Í »ó°ü¾øÀÌ ¿¹ÈÄ¿¡ ´ëÇÑ Á¤º¸¸¦ ÁØ´Ù. 51-60 ¿°»öü »çÀÌÀÇ °í¹è¼ö¼ºÀÌ ¿¹Èİ¡ ÁÁÀº °ÍÀº ÀÌ¹Ì Àß ¾Ë·ÁÁ® ÀÖ´Ù.
  • acute mania
    ±Þ¼º Á¶Áõ, ±Þ¼º Á¶º´
  • acute mastoiditis
    ±Þ¼º À¯¾çµ¹±â¿°
    À¯¾çµ¹±âÀÇ ±Þ¼º ¿°Áõ.
  • acute mediastinitis
    ±Þ¼º Á¾°Ýµ¿¿°
    °æºÎ·ÎºÎÅÍÀÇ °¨¿° È®»êÀ̳ª ½ÄµµÀÇ Ãµ°ø¿¡ ÀÇÇØ ÀϾ´Ù. °¨¿°Àº ÀϹÝÀûÀ¸·Î È­³ó¼ºÀÌ¸ç °á°úÀûÀ¸·Î ³ó¾çÀ» Çü¼ºÇÑ´Ù.
  • acute megakaryocytic leukemia
    ±Þ¼º °ÅÇÙ±¸¼º ¹éÇ÷º´
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
trophoneurotic atrophy Abnormalities of the skin, hair, nails, subcutaneous tissues and bone, caused by peripheral nerve lesions.
Synonym: neuritic atrophy, neurogenic atrophy, neurotrophic atrophy, trophic changes.
(05 Mar 2000)
essential progressive atrophy of iris Progressive atrophy of the iris without inflammatory signs, characterised by patchy loss of all layers of the iris with hole formation, migration of the pupil, degeneration of the corneal endothelium, peripheral anterior synechiae, and secondary glaucoma; usually unilateral, predominantly affecting women in their middle years.
(05 Mar 2000)
exhaustion atrophy Atrophy, especially of glandular cells, believed to result from excessive functional activity or overstimulation.
(05 Mar 2000)
juvenile muscular atrophy Slowly progressive proximal muscular weakness and wasting, beginning in childhood, caused by degeneration of motor neurons in the anterior horns of the spinal cord; onset usually between 2 and 17 years of age; usually autosomal recessive inheritance.
Synonym: juvenile muscular atrophy, Kugelberg-Welander disease, Wohlfart-Kugelberg-Welander disease.
(05 Mar 2000)
juvenile spinal muscular atrophy Slowly progressive proximal muscular weakness and wasting, beginning in childhood, caused by degeneration of motor neurons in the anterior horns of the spinal cord; onset usually between 2 and 17 years of age; usually autosomal recessive inheritance.
Synonym: juvenile muscular atrophy, Kugelberg-Welander disease, Wohlfart-Kugelberg-Welander disease.
(05 Mar 2000)
facioscapulohumeral atrophy A relatively benign type of muscular dystrophy commencing in childhood and slowly progressive; characterised by wasting and weakness, sometimes asymmetrical, mainly of the muscles of the face, shoulder girdle, and arms; autosomal dominant inheritance.
Synonym: facioscapulohumeral atrophy, Landouzy-Dejerine dystrophy.
(05 Mar 2000)
familial spinal muscular atrophy Transmitted as autosomal recessive on chromosome 5q. Progressive dysfunction of the anterior horn cells in the spinal cord and brainstem cranial nerves with profound weakness and bulbar dysfunction occurring in the first two years of life. Three groups, based on age of clinical onset, are recognised.
Synonym: familial spinal muscular atrophy, Hoffmann's muscular atrophy, infantile muscular atrophy, infantile progressive spinal muscular atrophy, progressive infantile spinal muscular atrophy, Werdnig-Hoffmann disease, Werdnig-Hoffmann muscular atrophy.
(05 Mar 2000)
Kienbock's atrophy Acute atrophy of bone in an extremity following inflammation.
(05 Mar 2000)
fatty atrophy Fatty infiltration secondary to an atrophy of the essential elements of an organ or tissue.
(05 Mar 2000)
Zimmerlin's atrophy A variety of hereditary progressive muscular atrophy in which the atrophy begins in the upper half of the body.
(05 Mar 2000)
Leber's hereditary optic atrophy Hereditary degeneration of the optic nerve and papillomacular bundle with resulting rapid loss of central vision, progressive for several weeks, then usually stationary with permanent central scotoma; age of onset is variable, most often in the third decade; more males than females are affected and transmission is cytoplasmic and strictly on the female side. Mutation on the mitochondrial chromosome involved, which presumably interacts with an X-linked mutant. This mechanism may explain the bizarre sex ratio, which differs significantly from one country to another.
(05 Mar 2000)
linear atrophy Bands of thin wrinkled skin, initially red but becoming purple and white, which occur commonly on the abdomen, buttocks, and thighs at puberty and/or during and following pregnancy, and result from atrophy of the dermis and overextension of the skin; also associated with ascites and Cushing's syndrome.
Synonym: atrophoderma striatum, lineae albicantes, lineae atrophicae, linear atrophy, stretch marks, stria, striae atrophicae, striate atrophy of skin, traction atrophy, vergeture.
(05 Mar 2000)
abdomen, acute Clinical syndrome characterised by abdominal pain of great severity associated with other symptoms and signs, usually those of acute peritonitis, which might well be the result of a ruptured abdominal viscus or a similar abdominal catastrophe requiring urgent surgical operation.
(12 Dec 1998)
acute 1. Sharp, poignant.
2. Having a short and relatively severe course.
Origin: L. Acutus = sharp
(18 Nov 1997)
acute abdomen Any serious acute intra-abdominal condition (such as appendicitis) attended by pain, tenderness, and muscular rigidity, and for which emergency surgery must be considered.
Synonym: surgical abdomen.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
ÅëÇÕ°Ë»ö ¿Ï·á